Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants

Zishuo Cheng1, Christopher R Bethel2, Pei W Thomas3

  • 1Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio, USA.

Insights

Metallo-β-lactamases (MBLs) are a growing threat, with IMP variants showing increased carbapenem resistance. Their evolution is driven by distinct selective pressures, unlike other MBLs.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Evolutionary Biology

Background:

  • Metallo-β-lactamases (MBLs) pose a significant clinical challenge due to their ability to neutralize β-lactam antibiotics.
  • No inhibitors for MBLs are currently available, and numerous variants have emerged within MBL subfamilies.

Purpose of the Study:

  • To investigate the evolution of imipenemase (IMP) genes (blaIMP) and their clinical implications.
  • To understand the molecular mechanisms behind increased antibiotic resistance in IMP variants.

Main Methods:

  • Site-directed mutagenesis was used to generate 20 clinically derived IMP-1 like variants in Escherichia coli DH10B.
  • Biochemical, biophysical, and molecular modeling studies were performed to compare key IMP variants (IMP-1, IMP-6, IMP-10, IMP-78).
  • Minimum inhibitory concentration (MIC) values were assessed for various IMP variants.

Main Results:

  • IMP-1 like variants with S262G or V67F substitutions demonstrated enhanced resistance to carbapenems and reduced resistance to ampicillin.
  • The IMP-78 (S262G/V67F) variant exhibited the most substantial changes in MIC values compared to IMP-1.
  • Unlike NDM and VIM variants, IMP-1 like variants did not provide a survival advantage under limited zinc conditions.

Conclusions:

  • The evolution of IMP-6, IMP-10, and IMP-78 variants is influenced by unique selective pressures.
  • Understanding these evolutionary dynamics is crucial for developing strategies against MBL-mediated antibiotic resistance.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
810
Antibiotic Selection00:57

Antibiotic Selection

Overview
57.6K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
777
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
277
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.8K